New York, NY -- (SBWIRE) -- 03/06/2013 -- Halliburton Company (NYSE: HAL) posted similar results to Schlumberger, a decrease in profits but an increase in revenues, even though the fall was far greater and the increase in revenues was much smaller as compared to Schlumberger.
The company’s revenues climbed by a more modest 3.3% to $7.29 billion, while its net income fell by 26.2% to $669 million or $0.72 per share. Analysts were expecting earnings of $0.61 per share.
Despite the company’s heavy exposure to North America, a region where drilling activity was down in Q4-2012, Halliburton’s revenues still increased due to strong performances from Middle East/Asia and Latin America regions.
HAL is a part of the Energy sector, which includes companies such as Schlumberger N.V. (SLB) and Oceaneering International, Inc. (OII).
Find out if this is the moment investors have been waiting for before trading HAL here: http://www.wallstreetscoop.net/market-scan/?symbol=HAL
Gilead Sciences Inc. (NASDAQ: GILD) announced detailed 24-week results from a Phase 2 study (Study 102) evaluating a once-daily single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection.
A regimen of TAF 10 mg/elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg was found to be similar to Stribild® (elvitegravir 150 mg/cobicistat 150 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) based on the percentage of patients with HIV RNA levels less than 50 copies/mL at 24 weeks of treatment.
These findings were presented in a latebreaker session (Abstract #99LB) at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) taking place in Atlanta.
Find out more on GILD by getting the free and full daily trend analysis report here: http://www.wallstreetscoop.net/market-scan/?symbol=CILD
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.
WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetScoop.net
WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetscoop.net/disclaimer/
Wall Street Scoop
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)